Sol-Gel Technologies Ltd. (SLGL)
Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates. Twyneo, an innovative, non-antibiotic topical cream designed for once-daily application, has successfully concluded Phase III trials for treating acne vulgaris. Similarly, Epsolay, another topical cream administered once a day, has also completed its Phase III studies, targeting papulopustular rosacea. Advancing through Phase I clinical trials is SGT-210, intended for palmoplantar keratoderma. Furthermore, the company is investigating Erlotinib, Tapinarof, and Roflumilast as potential treatments for psoriasis and various other medical conditions. Beyond its proprietary offerings, the company also engages in creating generic versions of topical dermatological medications. Sol-Gel Technologies maintains a strategic partnership with Perrigo. Established in 1997, the company maintains its headquarters in Ness Ziona, Israel.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Sol-Gel Technologies Ltd.
Nasdaq bars a compliance period at 1:250
- 1:10Reverse splitMay 5, 202510 shares → 1
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Revenue | $19.39M | $11.54M | $1.55M | $3.88M | $31.27M | $8.77M | $22.9M | $129K | $174K | $0 | $0 | $0 |
| YoY Growth | 68.0% | 642.5% | -60.0% | -87.6% | 256.5% | -61.7% | 17655.0% | -25.9% | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $12.68M | $20.38M | $27.91M | $40.58M | $28.15M | $300K | $359K | $300K | $0 |
| Gross Profit | $19.39M | $11.54M | $1.55M | -$8.8M | $10.89M | -$19.14M | -$17.67M | -$28.02M | -$126K | -$359K | -$300K | $0 |
| Gross Margin | 100.0% | 100.0% | 100.0% | -226.6% | 34.8% | -218.2% | -77.2% | -21718.6% | -72.4% | - | - | - |
| Research and Development | $22.8M | $17.8M | $23.54M | $12.68M | $20.38M | $27.91M | $40.58M | $28.15M | $25.8M | $17.02M | $7.18M | $2.93M |
| Selling, General, and Administrative | $4.18M | $5.75M | $7.37M | $7.45M | $8.45M | $11.09M | $8.28M | $5.5M | $6M | $3.73M | $2.46M | $1.88M |
| Other | -$54K | $0 | -$55K | -$12.68M | -$20.91M | -$27.91M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $26.93M | $23.55M | $30.86M | $7.45M | $7.93M | $11.09M | $48.85M | $33.65M | $31.81M | $20.76M | $9.65M | $4.81M |
| Operating Income (EBIT) | -$7.54M | -$12.01M | -$29.3M | -$16.24M | $2.96M | -$30.23M | $25.95M | -$33.52M | -$31.63M | -$20.76M | -$9.65M | -$4.81M |
| Operating Margin | -38.9% | -104.1% | -1885.8% | -418.3% | 9.5% | -344.7% | 113.3% | -25985.3% | -18179.9% | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $1.41M | $1.43M | $2.07M | $1.32M | $257K | $943K | $1.37M | $1.32M | $65K | $0 | $0 | $40K |
| Other Income (Expense) | $1.41M | $1.43M | $2.07M | $1.32M | $257K | $943K | $1.37M | $1.32M | $65K | -$15K | -$13K | -$40K |
| Income Before Tax (EBT) | -$6.13M | -$10.58M | -$27.24M | -$14.92M | $3.22M | -$29.29M | -$24.58M | -$32.2M | -$31.57M | -$20.77M | -$9.66M | -$4.85M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $33K | $0 | -$65K | $15K | $13K | $0 |
| Net Income | -$6.13M | -$10.58M | -$27.24M | -$14.92M | $3.22M | -$29.29M | -$24.61M | -$32.2M | -$31.57M | -$20.77M | -$9.66M | -$4.85M |
| Net Income Margin | -31.6% | -91.7% | -1752.8% | -384.3% | 10.3% | -333.9% | -107.4% | -24963.6% | -18142.5% | - | - | - |
| Supplementary Data | ||||||||||||
| EPS | -2.20 | -3.79 | -10.01 | -0.65 | 1.40 | -1.30 | -1.26 | -1.80 | -1.76 | -1.77 | -0.82 | -1.81 |
| Diluted EPS | -2.20 | -3.79 | -10.01 | -0.65 | 0.14 | -1.30 | -1.26 | -1.80 | -1.76 | -1.77 | -0.82 | -1.81 |
| Weighted Average OS | 2.79M | 2.79M | 2.71M | 23.13M | 23.06M | 22.57M | 19.53M | 17.87M | 17.99M | 11.74M | 11.74M | 2.68M |
| EBITDA | -$7.43M | -$11.78M | -$28.96M | -$15.68M | $3.84M | -$29.29M | -$25.06M | -$32.76M | -$31.16M | -$20.4M | -$9.35M | -$4.58M |
| EBITDA Margin | -38.3% | -102.1% | -1863.8% | -403.9% | 12.3% | -333.9% | -109.4% | -25394.6% | -17909.2% | - | - | - |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $11.03M | $19.49M | $7.51M | $12.45M | $20.09M | $7.12M | $9.41M | $5.33M | $5.02M | $7M | $5.89M | $594K |
| Short-Term Investments | $12.97M | $4.44M | $30.48M | $21.18M | $23.16M | $43.05M | $40.97M | $57.66M | $4M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $24M | $23.93M | $38M | $33.63M | $43.24M | $50.17M | $50.38M | $62.99M | $9.02M | $7M | $5.89M | $594K |
| Accounts Receivable | $1.97M | $3.6M | $377K | $7.92M | $13.06M | $2.15M | $4.12M | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1M | $3.77M | $2.79M | $0 | $0 | $0 | $0 | $0 | $0 | $472K | $244K | $0 |
| Total Current Assets | $26.97M | $31.3M | $41.17M | $43.05M | $57.11M | $53.4M | $55.79M | $65.97M | $10.55M | $8.3M | $6.14M | $839K |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $1.17M | $1.63M | $2.15M | $1.54M | $2.55M | $3.71M | $4.35M | $2.6M | $2.31M | $798K | $785K | $771K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1.32M | $2.31M | $1.28M | $1.29M | $8.7M | $0 | $472K | $0 | $1.77M | $0 | $92K | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $455K | $608K | $681K | $749K | $830K | $2.05M | $684K | $1.1M | $680K | $1.89M | $1.23M | $776K |
| Total Long-Term Assets | $2.95M | $4.55M | $4.12M | $3.57M | $12.08M | $5.76M | $5.51M | $3.71M | $4.77M | $2.69M | $2.1M | $1.55M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $29.92M | $35.85M | $45.29M | $46.63M | $69.19M | $59.16M | $61.3M | $69.68M | $15.31M | $10.98M | $8.24M | $2.39M |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $735K | $1.26M | $154K | $251K | $766K | $1.2M | $1.71M | $2.92M | $534K | $667K | $311K | $247K |
| Short-Term Debt | $495K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $65.34M | $37.34M | $17.34M | $3.33M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $4.49M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $6.17M | $5.29M | $4.52M | $3.33M | $11.69M | $5.96M | $6.5M | $4.89M | $67.2M | $41.63M | $19.14M | $4.66M |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $439K | $833K | $915K | $1.03M | $1.09M | $1.05M | $958K | $878K | $810K | $694K | $626K | $0 |
| Total Long-Term Liabilities | $935K | $1.71M | $2.12M | $1.09M | $1.9M | $2.35M | $2.33M | $878K | $810K | $694K | $626K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $7.11M | $7M | $6.64M | $4.42M | $13.6M | $8.31M | $8.84M | $5.77M | $68.01M | $42.32M | $19.76M | $4.66M |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $774K | $774K | $774K | $638K | $638K | $635K | $561K | $520K | $82K | $82K | $82K | $82K |
| Retained Earnings | -$237.01M | -$230.88M | -$220.3M | -$193.06M | -$178.14M | -$181.36M | -$152.07M | -$127.46M | -$95.26M | -$63.69M | -$42.92M | -$33.26M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.98M | -$1.51M | -$1.15M | $0 |
| Other Stockholders' Equity | $259.05M | $258.96M | $258.17M | $234.64M | $233.1M | $231.58M | $203.98M | $190.85M | $42.48M | $32.27M | $31.32M | $30.19M |
| Total Equity | $22.81M | $28.85M | $38.64M | $42.21M | $55.59M | $50.85M | $52.47M | $63.91M | -$52.7M | -$31.34M | -$11.52M | -$2.99M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $29.92M | $35.85M | $45.29M | $46.63M | $69.19M | $59.16M | $61.3M | $69.68M | $15.31M | $10.98M | $8.24M | $1.67M |
| Supplementary Data | ||||||||||||
| Total Debt | $991K | $1.31M | $1.65M | $772K | $1.59M | $1.97M | $2.04M | $0 | $65.34M | $37.34M | $17.34M | $3.33M |
| Net Debt | -$10.04M | -$18.18M | -$5.86M | -$11.68M | -$18.49M | -$5.15M | -$7.37M | -$5.33M | $60.31M | $30.34M | $11.44M | $2.74M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$6.13M | -$10.58M | -$27.24M | -$14.92M | $3.22M | -$29.29M | -$24.61M | -$32.2M | -$31.57M | -$20.77M | -$9.66M | -$4.85M |
| Depreciation & Amortization | $109K | $233K | $342K | $562K | $880K | $946K | $887K | $762K | $471K | $359K | $300K | $225K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | -$96K | $138K | $65K | $29K | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $786K | $1.86M | $1.53M | $687K | $1.22M | $2.55M | $4.65M | $3.97M | $952K | $1.13M | $0 |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | $1.63M | -$4.2M | $7.54M | $12.55M | -$18.31M | $1.97M | -$4.12M | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $1.69M | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $820K | $780K | $1.47M | -$8.3M | $5.62M | -$542K | $938K | $3.03M | -$2.49M | $2.5M | $449K | $0 |
| Other Working Capital | $3.75M | -$981K | -$1.34M | -$709K | $274K | $219K | $0 | -$1.36M | -$199K | -$358K | -$710K | -$141K |
| Total Working Capital Change | $6.19M | -$4.4M | $7.67M | $3.54M | -$12.44M | $1.64M | -$1.45M | $3.33M | -$3.15M | $957K | -$261K | -$141K |
| Other Non-Cash Items | $148K | $74K | -$361K | -$188K | $55K | $104K | $50K | -$5K | $6.18M | $8K | $448K | -$66K |
| Net Cash from Operating | $322K | -$13.89M | -$17.73M | -$9.48M | -$7.69M | -$25.24M | -$22.5M | -$23.47M | -$24.09M | -$18.5M | -$8.04M | -$4.83M |
| Investing Activities | ||||||||||||
| Capital Expenditures | -$47K | -$2K | -$134K | -$171K | -$143K | -$449K | -$597K | -$1.05M | -$1.93M | -$385K | -$291K | -$268K |
| Acquisitions | $54K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$14.08M | $0 | -$23.98M | -$10.01M | -$6.76M | -$53.72M | -$38.7M | -$71.78M | -$4.01M | -$15K | -$8K | $0 |
| Sales of Investments | $5.51M | $26.69M | $14.29M | $11.88M | $26.78M | $51.5M | $55.33M | $18.09M | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$20K | $6K | $74K | $0 | -$5K | -$21K | -$10K | $8K | -$4.01M | $9K | $89K | $1.17M |
| Net Cash from Investing | -$8.58M | $26.69M | -$9.74M | $1.7M | $19.87M | -$2.69M | $16.02M | -$54.73M | -$5.94M | -$391K | -$210K | $897K |
| Financing Activities | ||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $6K | $0 | $21.54M | $15K | $505K | $26.31M | $10.61M | $78.78M | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $268K | $0 | $332K | $151K | $0 | $44K | $0 | $0 | $0 | $3.33M |
| Net Cash from Financing | $6K | $0 | $21.81M | $15K | $837K | $26.46M | $10.61M | $78.82M | $28M | $20M | $13.57M | $3.33M |
| Forex Effect | -$204K | -$1K | -$73K | $133K | -$55K | -$12K | -$50K | $34K | $50K | -$8K | -$17K | -$74K |
| Net Change in Cash | -$8.46M | $12.8M | -$5.74M | -$7.64M | $12.96M | -$1.49M | $4.09M | $651K | -$1.98M | $1.11M | $5.3M | -$672K |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | $322K | -$13.89M | -$17.73M | -$9.48M | -$7.69M | -$25.24M | -$22.5M | -$23.47M | -$24.09M | -$18.5M | -$8.04M | -$4.83M |
| Capital Expenditure | -$47K | -$2K | -$134K | -$171K | -$143K | -$449K | -$597K | -$1.05M | -$1.93M | -$385K | -$291K | -$268K |
| Free Cash Flow | $275K | -$13.89M | -$17.86M | -$9.65M | -$7.83M | -$25.69M | -$23.1M | -$24.52M | -$26.01M | -$18.88M | -$8.34M | -$5.1M |
| Cash at Beginning | $19.49M | $7.86M | $13.6M | $21.23M | $8.27M | $9.76M | $5.67M | $5.02M | $7M | $5.89M | $594K | $1.27M |
| Cash at End | $11.03M | $20.66M | $7.86M | $13.6M | $21.23M | $8.27M | $9.76M | $5.67M | $5.02M | $7M | $5.89M | $594K |